Skip to main content

Table 2 Significant bacterial isolates from specimens submitted during work up for suspected HAI

From: Prospective surveillance of healthcare associated infections in a Cambodian pediatric hospital

Organism

Sample type

Syndrome

Sensitivity to 3GC

Empirical Rx

Empirical Rx changed

Acinetobacter baumanii

ETT

VAP

R

Imi/mero

No

Acinetobacter baumanii

B/C

VAP

R

Ceftriaxone

Yes

Coliforma

B/C

Gastro

S

Imi/mero

No

Enterobacter cloacae

B/C

Primary BSI

R

Imi/mero

No

Enterobacter cloacae

B/C

Gastro

S

Imi/mero

No

Enterobacter cloacae

B/C

Line

R

Imi/mero

No

Escherichia coli

Urine

UTI

R

Imi/mero

No

Escherichia coli

B/C & urine

UTI

R

Imi/mero

No

Escherichia coli Pseudomonas aeruginosa

B/C

NEC

S

Int-R

Imi/mero

No

Klebsiella pneumoniae

B/C

HAP

R

Imi/mero

No

Klebsiella pneumoniae

B/C

VAP

R

Imi/mero

No

Moraxella catarrhalis

B/C

HAP

S

Ceftriaxone

No

Staphylococcus aureus (MRSA)

B/C

SSTI

R

Imi/mero

Yes

Stenotrophomonas maltophilia Enterococcus species

B/C

NEC

Int-R

Int-R

Imi/mero

Yes

Streptococcus pyogenes

B/C

SSTI

S

Cloxacillin

Yes

Yeast

B/C

Gastro

Int-R

Ceftriaxone

Yes

  1. 3GC third generation cephalosporin, B/C blood culture, BSI blood stream infection, ETT endotracheal tube secretions, Gastro gastroenteritis, HAP hospital-acquired pneumonia, Imi/mero carbapenem (imipenem or meropenem), Int-R intrinsically resistant, MRSA methicillin resistant Staphylococcus aureus, NEC necrotizing enterocolitis, R resistant, Rx treatment, S sensitive, SSTI skin and soft tissue infection, UTI urinary tract infection, VAP ventilator-associated pneumonia,
  2. aThis coliform could not be identified to a satisfactory level using the biochemistry short set or bioMerieux API kits available at AHC